Date: 2012-10-18
Type of information: Production agreement
Compound: undisclosed product
Company: Albany Molecular Research (USA) Shire (UK-USA)
Therapeutic area: undisclosed
Type agreement: manufacturing
production
Action mechanism:
Disease: undisclosed
Details: Albany Molecular Research (AMRI) has entered into a multi-year supply agreement for an undisclosed product with Shire US Manufacturing Inc., whose parent company, Shire plc, is a global company that focuses its business on behavioral health, gastro intestinal diseases, rare diseases and regenerative medicine. The agreement extends a previously existing agreement between the two companies. The terms of the agreement are confidential.
Financial terms:
Latest news:
